| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3244ba8390b1f290f4ba36389c82488b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ebde23580300570403d970852f8a884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a751b23edd635aa127f4acf448dd3e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b12dab5326256debd7d3a50425dcbbec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67d8461385a76b472cbe04da41f3efd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86965244d49e01279858dd06e96eab38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a2f869eb02fd5fa259a99ed695d7ebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c8fd2c7c1b2d0033207dbb06f059e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ec816827b1241790ca7ea8323a2a0cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ca5c68296243d19dca4dced68dd066c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fc22448683014d252360953345f242f |
| publicationDate |
2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2924438-A1 |
| titleOfInvention |
IGFBP7 for diagnosing diastolic dysfunction |
| abstract |
The present invention relates to a method for diagnosing and/or grading diastolic dysfunction or at least one structural or functional abnormality associated with diastolic dysfunction. The method comprises measuring the level of IGFBP7 (Insulin like growth factor binding protein 7) and, optionally, the level of at least one further marker in a patient suffering from heart failure, and comparing the level to a reference level. Further envisaged is a method of monitoring diastolic function in a patient suffering from heart failure. Also encompassed by the present invention are kits and devices adapted to carry out the method of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022034159-A1 |
| priorityDate |
2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |